Skip to Content

Tag: Needham & Co.


Report: Providers anticipate sleep rebound

September 28, 2022HME News Staff

NEW YORK – HME providers saw a 6.3% decline in their sleep patient volume in the last 12 months, but they expect double-digit growth in the next 12 months, according to the third quarter HME Sleep and Oxygen Survey from Needham.  The decline in sleep is mainly due to a shortage in flow generators. The eventual re-entry of Philips into the flow generator market appears likely to come mostly at the expense of smaller competitors rather than ResMed, according to the survey.  Respondents...

CPAP recall, Home Oxygen, Home sleep, Needham & Co.

Read Full Articlered right arrow icon


Providers hold off on ordering—for now

December 20, 2018HME News Staff

NEW YORK - The majority of HME providers are reducing or delaying orders for oxygen and CPAP equipment, but that is likely to be temporary, according to a new survey for the fourth quarter of 2018 from Needham & Company.Sixty three percent of respondents said they would reduce or delay orders for oxygen equipment in response to an any willing provider provision set to go into effect Jan. 1 for Medicare, according to the survey of 150 providers.Respondents said they would also reduce or delay orders...

CPAP, Home Oxygen, Needham & Co., POCs

Read Full Articlered right arrow icon

Also Noted

Growth in the sleep market continues

September 12, 2018HME News Staff

BOSTON - Sleep center patient volume grew 7% in the last 12 months and is expected to grow 9% in the next 12 months, according to the results of a new survey conducted by Needham & Co. ResMed looks likely to lose 2% of flow generator prescription share, but gain branded mask prescription share. For flow generators, Respironics' share is up 1.1%, Fisher & Paykel's share is flat and other companies' share is up .8%. ResMed's mask ratings are slightly above its competitors in all three mask categories....

Needham & Co., ResMed, sleep patients

Read Full Articlered right arrow icon


In brief: POCs on the rise, therapeutic shoe bill introduced

June 29, 2018HME News Staff

BOSTON - HME providers will continue to increase adoption of portable oxygen concentrators, to the tune of about 30% over the next 12 months, according to a 2Q 2018 survey on oxygen and sleep trends from Needham & Co.Applied Home Healthcare's OxyGo Fit and OxyGo were the highest rated POCs at 5.9 and 5.8 out of 7, followed by Inogen's G4 and G3, both at 5.7, and Respironics' SimplyGo Mini at 5.1.Survey respondents identify an average of 42% of their ambulatory patients as candidates for POCs, a number...

BOC, Diabetic Shoes, FRESCA Medical, Motivo, Needham & Co., VGM

Read Full Articlered right arrow icon